We are very committed to making clinical trial information more transparent, and we are currently in consultation about the best way of doing that. As the clinical trial sites become multinational, the question of whether we should build a Canadian-only site, or whether we should require companies to put their clinical trial information on international WHO-sanctioned sites, which we have been encouraging companies to do, is a question that is still outstanding.
Canadians, I think, are interested. Some of these clinical trials are with patients who have very specific conditions. You'll be interested, as a parent or as a family member, in knowing what is happening in the sites in Canada and also whether those drugs are being tested internationally.